Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank72
3Y CAGR+28.4%
5Y CAGR-14.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+28.4%/yr
vs +66.0%/yr prior
5Y CAGR
-14.4%/yr
Recent acceleration
Acceleration
-37.6pp
Decelerating
Percentile
P72
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.50% |
| Q3 2025 | 3.56% |
| Q2 2025 | 2.67% |
| Q1 2025 | -17.06% |
| Q4 2024 | -22.20% |
| Q3 2024 | 63.71% |
| Q2 2024 | 15.77% |
| Q1 2024 | -2.60% |
| Q4 2023 | 6.02% |
| Q3 2023 | -5.25% |
| Q2 2023 | 15.67% |
| Q1 2023 | -23.18% |
| Q4 2022 | 7.80% |
| Q3 2022 | 2.14% |
| Q2 2022 | 13.85% |
| Q1 2022 | -16.23% |
| Q4 2021 | 16.91% |
| Q3 2021 | 4.35% |
| Q2 2021 | 22.05% |
| Q1 2021 | -16.08% |
| Q4 2020 | 35.97% |
| Q3 2020 | 13.15% |
| Q2 2020 | 11.55% |
| Q1 2020 | -9.66% |
| Q4 2019 | 14.52% |
| Q3 2019 | 1.50% |
| Q2 2019 | 41.31% |
| Q1 2019 | -13.39% |
| Q4 2018 | 64.70% |
| Q3 2018 | 35.57% |
| Q2 2018 | 25.11% |
| Q1 2018 | -32.31% |
| Q4 2017 | 49.22% |
| Q3 2017 | 26.61% |
| Q2 2017 | 12.38% |
| Q1 2017 | -34.36% |
| Q4 2016 | 135.19% |
| Q3 2016 | -46.52% |
| Q2 2016 | 14.59% |
| Q1 2016 | -31.12% |